Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome

Chinese Medical Journal

Volumn 120, Issue 17, 2007, Pages 1477-1481

  Zhang, Xi Long ^a   Yin, Kai Sheng ^a   Li, Chong ^a   Jia, En Zhi ^a   Li, Yan Qun ^a   Gao, Zhao Fang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Continuous positive airway pressure; Mean arterial pressure; Obstructive sleep apnea syndrome

Indexed keywords

ADIPONECTIN;

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; HUMAN; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SLEEP APNEA SYNDROME; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

EID: 34848855726     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200709010-00002     Document Type: Article

References (22)

1. Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future. Circulation 2004; 109: 951-957.
2. Peters RW. Obstructive sleep apnea and cardiovascular diseases. Chest 2005; 127: 15-22.
3. Zhang XL, Yin KS, Wang H, Su SC. Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 2006; 73: 73-77.
4. Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006; 64: 12-19.
5. Masserini B, Morpurgo PS, Donadio F, Baldessari C, Bossi R, Beck-Peccoz P, et al. Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 2006; 29: 700-705.
6. Zhang XL, Yin KS, Mao H, Wang H, Yang Y. Serum adiponectin level in patients with obstructive sleep apnea hypopnea syndrome. Chin Med J 2004; 117: 1603-1606.
7. Iwashima Y, Katsuya T, Ishikawa Y, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43:1318-1323.
8. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006; 129:1459-1467.
9. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667-689.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
11. Vionnet N, Hani El-H, Dupont S, Gallina, S, Francke S, Dotte S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000; 67: 1470-1480.
12. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29-33.
13. Tilg H, Wolf AM. Adiponectin: a key fat-derived molecule regulating inflammation. Expert Opin Ther Targets 2005; 9: 245-251.
14. Kasasbeh E, Chi DS, Krishnaswamy G. Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med J 2006; 99: 58-67.
15. Kleiblova P, Springer D, Haluzik M. The influence of hormonal changes during menstrual cycle on serum adiponectin concentrations in healthy women. Physiol Res 2006; 55: 661-666.
16. Wang H, Zhang XL, Yang Y, Yin KS, Huang GQ. Relationship between sleep apnea hypopnea syndrome cardiovascular events in elderly Chinese snorers. Chin Med J 2002; 115: 1829-1832.
17. Martinez-Garcia MA, Gomez-Aldaravi R, Soler-Cataluna JJ, Martinez TG. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J 2007; 29; 951-957.
18. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese men with OSA. Eur Respir J 2007; 29; 720-727.
19. Alajmi M, Mulgrew AT, Fox J, Davidson W, Schulzer M, Mak E, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomised controlled trials. Lung 2007; 185: 61-72.
20. Hu X, Kang J, Xiao D, Wang W, Hou X, Yu R. The influence of nasal continual positive pressure on some vasoactive substances in patients with obstructive sleep apnea syndrome. Chin J Tuberc Respir Dis (Chin) 2002; 25: 36-38.
21. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993; 103: 722-727.
22. Baruzzi A, Riva R, Cirignotta F, Zucconi M, Cappelli M, Lugaresi E. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 1991; 14: 83-86.